NASDAQ:FPRX
Delisted
Five Prime Therapeutics Stock News
$38.00
+0 (+0%)
At Close: May 27, 2022
BRIEF-Five Prime Therapeutics Reports Q4 Loss Per Share $0.89
10:38pm, Thursday, 27'th Feb 2020
Five Prime Therapeutics Inc:
Five Prime Therapeutics: 4Q Earnings Snapshot
10:04pm, Thursday, 27'th Feb 2020
SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Thursday reported a loss of $31.4 million in its fourth quarter. On a per-share basis, the South San Francisco, California-bas
Five Prime Therapeutics: 4Q Earnings Snapshot
10:03pm, Thursday, 27'th Feb 2020
SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Thursday reported a loss of $31.4 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-bas
Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results
09:05pm, Thursday, 27'th Feb 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fat
Five Prime Therapeutics Q4 EPS $(0.89) Beats $(0.97) Estimate, Sales $3.21M Miss $4.65M Estimate
12:00am, Thursday, 27'th Feb 2020Five Prime Therapeutics to Present at Upcoming Healthcare Conference
09:22pm, Tuesday, 25'th Feb 2020
Five Prime Therapeutics to Present at Upcoming Healthcare Conference
Five Prime Therapeutics (FPRX) Scheduled to Post Quarterly Earnings on Thursday
10:20am, Tuesday, 25'th Feb 2020
Five Prime Therapeutics (NASDAQ:FPRX) will announce its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.98) per share for t
Five Prime Therapeutics Inc (NASDAQ:FPRX) Shares Acquired by Acadian Asset Management LLC
09:40am, Tuesday, 25'th Feb 2020
Acadian Asset Management LLC lifted its holdings in shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) by 60.3% during the 4th quarter, according to its most recent disclosure with the SEC. The insti
Q2 2020 Earnings Forecast for Five Prime Therapeutics Inc (NASDAQ:FPRX) Issued By Svb Leerink
07:32am, Tuesday, 25'th Feb 2020
Five Prime Therapeutics Inc (NASDAQ:FPRX) – Investment analysts at Svb Leerink issued their Q2 2020 EPS estimates for Five Prime Therapeutics in a research note issued to investors on Thursday, Febr
Five Prime Therapeutics (NASDAQ:FPRX) Lowered to Sell at Zacks Investment Research
10:42am, Monday, 24'th Feb 2020
Zacks Investment Research cut shares of Five Prime Therapeutics (NASDAQ:FPRX) from a hold rating to a sell rating in a research report sent to investors on Friday, Zacks.com reports. According to Zack
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
FY2023 Earnings Forecast for Five Prime Therapeutics Inc (NASDAQ:FPRX) Issued By Wedbush
08:16am, Sunday, 23'rd Feb 2020
Five Prime Therapeutics Inc (NASDAQ:FPRX) – Stock analysts at Wedbush dropped their FY2023 earnings per share (EPS) estimates for Five Prime Therapeutics in a note issued to investors on Tuesday, Fe
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
12:00am, Sunday, 23'rd Feb 2020Five Prime Therapeutics (NASDAQ:FPRX) & Taro Pharmaceutical Industries (NASDAQ:TARO) Critical Survey
10:24am, Saturday, 22'nd Feb 2020
Five Prime Therapeutics (NASDAQ:FPRX) and Taro Pharmaceutical Industries (NYSE:TARO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the st
